Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Pretreatment tumor diameter/volume and pelvic lymph node status assessed by magnetic resonance imaging for uterine cervical carcinoma treated with concurrent chemotherapy and radiotherapy
Journal of Obstetrics and Gynaecology Research, 09/05/08
Kim HJ et al. - Tumor volume and enlarged pelvic lymph nodes seen on pretreatment MRI were significant prognostic factors for pts with invasive cervical carcinoma treated with concurrent chemotherapy and radiotherapy
Methods- Study of the prognostic value of tumor diameter and volume and pelvic lymph node status assessed by MRI in pts with uterine cervical carcinoma treated with concurrent chemotherapy and radiotherapy
- Review of 98 pts diagnosed with stage IB to IIIB cervical carcinoma Tumor diameter evaluated in T2-weighted imageTumor volume calculated by equation (volume = width × length × height × π/6) as ellipsoid approximation
- Univariate and multivariate analyses for prognostic factors for overall survival (OS), disease-free survival (DFS), pelvic control (PC) and distant metastasis-free survival (DMFS)
- 5-yr rates: OS 59.8%; DFS 57.3%; PC 67.9%; DMFS 78.8%
- In univariate analyses, large MRI tumor diameter (≥4 cm), large tumor volume (≥30 mL), pelvic enlarged pelvic lymph nodes, large clinical diameter (≥4 cm) and FIGO stage had a statistically significant unfavorable effect on OS and DFS
- In multivariate analyses, large tumor volume affected OS, DFS, PC, and DMFS; enlarged pelvic lymph nodes also affected OS
| Previous Article | Next Article |
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update: Endometrial Cancer
OBG Management, 07/02/09
Sentinel lymph node sampling in gynaecological cancers: Techniques and clinical applications
European Journal of Surgical Oncology, 06/05/09
Surveillance of patients after initial treatment of ovarian cancer
Critical Reviews in Oncology/Hematology, 06/11/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and mri features
American Journal of Roentgenology, 06/23/09
Prediction of malignant breast lesions from mri features: a comparison of artificial neural network and logistic regression techniques
Academic Radiology, 06/10/09
Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors
Acta Radiologica, 06/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


